| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 350.42 KB | Adobe PDF |
Advisor(s)
Abstract(s)
Osteosarcoma (OS) is a rare condition with very poor prognosis in a metastatic setting. Basic research has enabled a better understanding of OS pathogenesis and the discovery of new potential therapeutic targets. Phase I and II clinical trials are already ongoing, with some promising results for these patients. This article reviews OS pathogenesis and new potential therapeutic targets.
Description
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Keywords
Molecular targets Osteosarcoma Pathogenesis
Pedagogical Context
Citation
Int J Mol Sci. 2021 Jan 15;22(2):813
Publisher
MDPI